Ethics of testing drugs with readily available alternatives

Author： Garattini S.   de Andres-Trelles F.   Bertele V.   Bassi L.L.  

Publisher： Elsevier

ISSN： 0140-6736

Source： The Lancet, Vol.360, Iss.333, 2002-08, pp. : 647-647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Emergency Contraceptives Continue to be Available as Over the Counter Drugs?

By  

International Journal of User-Driven Healthcare (IJUDH), Vol. 1, Iss. 4, 2011-10 ,pp. : 53-60

IGI Global_journal

Access to resources Recommend Favorite

Do we need authorized orphan drugs when compounded medications are available?

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 38, Iss. 1, 2013-02 ,pp. : 1-2

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do we need authorized orphan drugs when compounded medications are available?

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 269-4727, Iss. 1, 2013-02 ,pp. : 1-2

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nanotechnological Strategies to Improve Water Solubility of Commercially Available Drugs

By  

Current Nanomedicine, Vol. 7, Iss. 2, 2017-07 ,pp. : 84-110

Bentham Science Publishers

Access to resources Recommend Favorite

Which drugs should we be testing for bioavailability [editorial]?

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 2, Iss. 1, 1975-02 ,pp. : 5-7

John Wiley & Sons Inc

Access to resources Recommend Favorite